microRNAs and prostate cancer
- 作者Xu-Bao Shi; Clifford G. Tepper; Ralph W. deVere White
- 卷第12卷
- 印刷ISSN1582-1838
- 电子ISSN1582-4934
- 文件大小114.67KB
- 发表时间2008
- DOI10.1111/j.1582-4934.2008.00420.x
- 页码1456-1465
Advances in assay of complement function and activationMorten Harboe; Ebbe Billmann Thorgersen; Tom Eirik Mollnes · 2011
The role of complement in liver injury, regeneration and transplantationThorgersen, Ebbe Billmann; Barratt-Due, Andreas; Haugaa, Håkon; Harboe, Morten; Pischke, Søren Erik; Nilsson, Per H.; Mollnes, Tom Eirik · Hepatology · 2019
Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparinMollnes, Tom Eirik; Videm, Vibeke; Götze, Otto; Harboe, Morten; Oppermann, Martin · The Annals of Thoracic Surgery · 1991
Quantitation of vitronectin and clusterin: Pitfalls and solutions in enzyme immunoassays for adhesive proteinsKolbjørn Høgåsen; Tom Eirik Mollnes; Jürg Tschopp; Morten Harboe · 1993
Properdin binding to complement activating surfaces depends on initial C3b depositionHarboe, Morten; Johnson, Christina; Nymo, Stig; Ekholt, Karin; Schjalm, Camilla; Lindstad, Julie K.; Pharo, Anne; Hellerud, Bernt Christian; Nilsson Ekdahl, Kristina; Mollnes, Tom Eirik; Nilsson, Per H. · Proceedings of the National Academy of Sciences · 2017
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplificationMorten Harboe; Peter Garred; Ellen Karlstrøm; Julie K. Lindstad; Gregory L. Stahl; Tom Eirik Mollnes · 2009
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in cord bloodBodil Salvesen; Erik Waage Nielsen; Morten Harboe; Ola Didrik Saugstad; Tom Eirik Mollnes · 2008